The latest news for Columbia's startup community
View this email in your browser
Happy holidays, and welcome back!  CTV started the year off with a bang, partnering with Fortress Biotech, Inc. to launch a new startup, Caelum Biosciences, Inc., and bringing the total number of new startups based on Columbia IP to 11 in the past 6 months alone. Caelum is focused on a promising new approach to the treatment of amyloid light chain (“AL”) amyloidosis. We wish the company all the best in bringing this exciting therapeutic to patients as quickly as possible! 

As we kick off the Spring semester at Columbia, I wanted to bring to your attention a particularly compelling series of opportunities taking place around campus in the months ahead for aspiring entrepreneurs and researchers interested in technology commercialization. CTV is pleased to be partnering on each of the following great opportunities:
Therapeutics Development Boot Camp: The Columbia Irving Institute’s new NIH-funded therapeutics accelerator, The Translational Therapeutics (TRx) Resource and CTV will be hosting a 5-part series focused on the key decision points along the drug development pathway for large market and rare disease indications. The boot camp is designed to provide a framework for researchers looking to learn more about translating early stage discoveries into clinical therapies and will provide guidance on the available resources at Columbia. The weekly sessions begin January 23rd and will cover unmet medical needs; competitive analysis within the therapeutics space; IP basics for bioscience; developing target product profiles; experimental drug design; and working with the FDA.  The events are open all Columbia community members.  For more information, please click here

Seminar series on life science entrepreneurship: On the evenings of March 7, March 14, April 4, and 19th, Columbia’s Precision Medicine Initiative will host a seminar series specifically focusing on launching startups around biomedical technologies.  Under the guidance of Dr. Tom Maniatis, the seminar series will cover the essentials for any life science startup: market analysis, value proposition, managing the regulatory pathway and clinical development, forming a leadership team, and raising funds from professional VCs. The events are open to all Columbia community members. For more information, contact Melanie Brazil

Medical Device Commercialization: How does a medical technology move from an initial idea to a product on the market? “Lab-to-Market: Accelerating Biomedical Innovation” (Spring semester, Wed 4-7pm, CUMC) is a semester-long workshop series, available for course credit if desired, designed to provide specialized frameworks and essential tools to clinicians, scientists, engineers and students (PhD, MBA and others) interested in delving into the issues and hurdles technologies will likely face in the move from lab to market. Innovative, experienced technical teams partner with students to identify the clinical need, stakeholder requirements, and business opportunity around a real-world envisioned technology in order to evaluate and increase its commercial potential, while receiving mentorship and guidance from seasoned business advisors, guest lecturers and instructors.  For more information or to participate in the course, please contact

Addressing clean-energy opportunities using entrepreneurship: based on Steve Blank’s Hacking for Defense class at Stanford, CTV, SEAS, SIPA and PowerBridgeNY will be partnering to host a full-semester class called Hacking for Energy. The 7 teams of cross-disciplinary students will be paired with energy industry companies such as SolarCity, GE, and Con Edison to tackle actual technology-based challenges these organizations are facing.  Along the way, students will learn not only about the dynamics of the energy industry, but also about how to apply Lean LaunchPad-based entrepreneurship methodologies to solve real-world problems.
Wednesday, 01/18, 6PM - The Business Potential of Engineering Biology - Hosted by CBSACNY this panel of pioneering scientists, investors, entrepreneurs, and business leaders will discuss the financing environment for emerging companies in this space, market opportunities, and what kind of business leadership can facilitate its growth.

Tuesday, 01/31, 4PM - CTV Office Hours for SEAS Faculty - In this open Q&A session, Orin Herskowitz, Executive Director of CTV and Senior VP for Intellectual Property & Technology Transfer and Satish Rao, Associate Director of Physical Sciences Licensing will give a brief overview of Columbia’s approach to intellectual property, technology commercialization, patent licensing and startups. All SEAS faculty and students are welcome.
Thursday, 02/02, 6:30PM
- Building Credible Financials for Early Stage Investors - David Ehrenberg, Founder, Partner and CEO of the Early Growth Financial Services will share his insight on how to tell a credible story through numbers.
Scientists and Entrepreneurs: From Here to There - Two leading members of the early-stage biotech community: Nina Tandon, CEO and co-founder of EpiBone, and Hemai Parthasarathy, Scientific Director of Breakout Labs and the Thiel Foundation (and investor in Epibone) discuss the current state of biotech investing, their lessons on life science entrepreneurship, and offer advice for those looking to launch their own companies in this space.
GeoLocked Removal Protector for equipment anti-theft protection and tracking  | Learn more

Augmented reality-based technique for guiding 3D rotation of physical objects | Learn more

Personalized graphical location indicator for digital maps | Learn more

Whole cell-based vaccine against pancreatic cancer | Learn more

3D model of human tumors for studying exosomes | Learn more

Columbia University has over 1200 active patent assets available for licensing. Click here to discover more
Have something you'd like to see included? Email
Copyright © 2017 Columbia Technology Ventures, All rights reserved. 

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list